Clinical Dilemmas in Breast Cancer: An Interactive Tumor Board Series
The Langham, Huntington Hotel & Spa, Pasadena
Pasadena, CA
November 14, 2009
| 7:30 am | Registration and Breakfast |
| 8:00 am | Welcome, Introductions, and Presession Survey Debu Tripathy |
| 8:15 am | Case 1: A 66-year-old woman with a 1.2-cm grade 2 ER+/PgR+/HER2– infiltrating ductal carcinoma with 0/3 sentinel nodes involved |
| Review of Case, Mammograms, and Pathology Adam Brufsky |
|
| Discussion of Recommendations C. Kent Osborne |
|
| Discussion of Recommendations Sara Hurvitz |
|
| Audience Discussion and Debate |
|
| 9:00 am | Case 2: A 69-year-old woman with a 2-cm grade 3 ER+/PgR+/HER2+ infiltrating ductal carcinoma with no lymph nodes involved and an LVEF of 52% |
| Review of Case, Mammograms, and Pathology Debu Tripathy |
|
| Discussion of Recommendations Adam Brufsky |
|
| Discussion of Recommendations C. Kent Osborne |
|
| Audience Discussion and Debate |
|
| 9:45 am | Case 3: A 37-year-old woman with a clinically staged 6-cm ER–/PgR–/HER2+ left upper outer quadrant infiltrating ductal carcinoma with clinically negative nodes |
| Review of Case, Mammograms, and Pathology Sara Hurvitz |
|
| Discussion of Recommendations Debu Tripathy |
|
| Discussion of Recommendations Debu Tripathy |
|
| Audience Discussion and Debate |
|
| 10:30 am | Break |
| 10:45 am | Case 4: A 55-year-old woman with T1 N1 ER+/PgR+/HER2+ breast cancer diagnosed 2 years ago treated with AC/paclitaxel plus HER2-targeted therapy followed by an aromatase inhibitor relapses in lung and liver 1 year after completing HER2-targeted therapy |
| Review of Case, Mammograms, and Pathology C. Kent Osborne |
|
| Discussion of Recommendations Sara Hurvitz |
|
| Discussion of Recommendations Debu Tripathy |
|
| Audience Discussion and Debate |
|
| 11:30 am | Case 5: A 61-year-old woman presenting with a 2-cm left breast mass, axillary adenopathy, and left hip pain is found to have a high-grade ER–/PgR–/HER2– infiltrating ductal carcinoma with bone and lung metastases and an ECOG PS of 0 |
| Review of Case, Mammograms, and Pathology Adam Brufsky |
|
| Discussion of Recommendations Sara Hurwitz |
|
| Discussion of Recommendations C. Kent Osborne |
|
| Audience Discussion and Debate |
|
| 12:15 pm | Postsession Survey and Closing Comments Debu Tripathy |
| 12:30 pm | Adjourn |